Tag Archives: Johnson’s

Johnson & Johnson’s COVID vaccine scores FDA panel backing, setting up likely authorization

A month after Johnson & Johnson’s COVID-19 vaccine posted positive data in a phase 3 study, the shot is almost ready for prime time. Late Friday, a key panel unanimously endorsed the vaccine for emergency use and sent it to the agency for an official decision. An FDA authorization for the one-dose vaccine would provide a quick lift… Read More »

Earnings bulletin: Johnson & Johnson’s second quarter of 2019

Johnson & Johnson kicked off the second-quarter earnings season Tuesday, reporting that its pharma unit outperformed struggling consumer healthcare and medical device segments. Pharma posted sales growth of 1.7% and operational growth of 4.4% to hit $ 10.53 billion in sales. Across J&J’s entire business, the company’s revenue sank 1.3% to $ 20.56 billion. At… Read More »